| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Financial Officer | SVP, COO &CFO | Director +2 more
3 companies
Labrucherie Gil M is a SVP, COO &CFO at NKTR, with reported holdings spanning 3 companies. Recent filings cover 6 purchases and 55 sales. Those positions are worth an estimated $1.5M at current prices.
Our model assigns Labrucherie Gil M a strong insider score of 84/100, based on 13 past trades. Over a 12-month horizon, 92.3% of those trades were profitable, with an average 12-month return of +74.2%.
Labrucherie Gil M's largest disclosed position is in NKTR as SVP, COO &CFO, worth about $1.2M. The recent filings there lean toward selling, a net 1,139,659 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Nov 16, 2020 | NKTR Nektar Therapeutics | SVP, COO &CFO | Sell | 8,276 | $16.93 | $140,112.68 | -3.5% | |
| Sep 17, 2020 | NKTR Nektar Therapeutics | SVP, COO &CFO | Sell | 2,000 | $19.96 | $39,920.00 | -0.8% | |
| Aug 18, 2020 | NKTR Nektar Therapeutics | SVP, COO &CFO | Sell | 8,245 | $19.67 | $162,199.15 | -3.4% | |
| May 19, 2020 | NKTR Nektar Therapeutics | SVP, COO &CFO | Sell | 7,727 | $22.54 | $174,154.77 | -3.1% | |
| Feb 18, 2020 | NKTR Nektar Therapeutics | SVP, COO &CFO | Sell | 5,938 | $22.35 | $132,714.30 | -2.3% | |
| Nov 18, 2019 | NKTR Nektar Therapeutics | SVP, COO &CFO | Sell | 8,863 | $17.97 | $159,268.11 | -3.9% | |
| Nov 13, 2019 | NKTR Nektar Therapeutics | SVP, COO &CFO | Sale+OE | 25,000 | $19.79 | $494,750.00 | -9.9% | |
| Oct 15, 2019 | NKTR Nektar Therapeutics | SVP, COO &CFO | Sale+OE | 25,000 | $15.83 | $395,750.00 | -9.9% | |
| Sep 16, 2019 | NKTR Nektar Therapeutics | SVP &Chief Financial Officer | Sale+OE | 25,000 | $20.52 | $513,000.00 | -14.1% | |
| Aug 16, 2019 | NKTR Nektar Therapeutics | SVP &Chief Financial Officer | Sell | 5,063 | $18.15 | $91,893.45 | -4.0% |